Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
761.130.03%
QQQ
709.610.06%
BTC/USD
77803.000.4979%
DIA
524.660.03%
GLD
393.070.06%
TLT
80.93-

Scribe Therapeutics Inc (SCTX) Stock Price, Quote, News & History

SCTXNASDAQ
Trade with Public
Trade with Public
$29.42
-0.32-1.08%
At close: Sep 14, 5:00 PM EST
$30.15
0.732.48%
After Hours: 7:56 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Scribe Therapeutics (SCTX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$29.97
Close
$29.42
Volume / Avg.
138.34K / 242.75K
Day Range
$28.55 - $30.53
52 Wk Range
17.31 - 39.60
Market Cap
$570.79M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
-
Days to Cover
2.63

Recent Scribe Therapeutics Inc News

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other stocks rallied on strong results.
Avi Kapoor

Gap Posts Upbeat Q2 Earnings, Joins Solstice Advanced Materials, N-Able And Other Big Stocks Moving Higher On Friday

U.S. stocks mixed, Nasdaq falls 0.1%. Gap Inc shares rise 15.2% on strong earnings and raised guidance. Other big gainers include Elastic NV, Solstice Advanced Materials Inc, and Pagerduty Inc.
Avi Kapoor

Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Monday

The text discusses recent gains in the stock market, particularly for companies like Napco Security Technologies and SuperX AI Technology. US stocks were mixed, with the Dow Jones index gaining 150 points. Napco Security Technologies rose after better-than-expected results. Other big gainers include SuperX AI, Evolution Metals, and Cleveland-Cliffs.
Avi Kapoor

Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday

Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX, SCSC, BTBT, MRVI, HIVE, AHG, TEM, MARA, LB also gain.
Avi Kapoor

PRO
HC Wainwright & Co. Reiterates Buy on Scribe Therapeutics, Maintains $60 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Scribe Therapeutics (NASDAQ:SCTX) with a Buy and maintains $60 price target.
Benzinga Newsdesk

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-37.85M
Investing Cash Flow (TTM)
59.16M
Financing Cash Flow (TTM)
-1.70M
Free Cash Flow (TTM)
-38.22M
Capital Expenditure (TTM)
-368.00K
Net Change in Cash (TTM)
19.61M

Analyst Trends and Forecast

4
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$563.67M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
14.46
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-6.18%
Earnings Yield % (FWD)
-8.47%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$8.71

Company Debt

Total Debt
$37.80M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$35.59M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$29.97
Close
$29.42
Volume / Avg.
138.34K / 242.75K
Day Range
$28.55 - $30.53
52 Wk Range
17.31 - 39.60
Market Cap
$570.79M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
-
Days to Cover
2.63

About

Sector
Health Care
Industry
Biotechnology
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Scribe Therapeutics (SCTX) stock?

A

You can purchase shares of Scribe Therapeutics (NASDAQ:SCTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Scribe Therapeutics (SCTX) competitors?

Q

What is the forecast, or price target, for Scribe Therapeutics (SCTX) stock?

A

Scribe Therapeutics has a consensus price target of $51.75.

Q

What is the current price for Scribe Therapeutics (SCTX)?

A

The stock price for Scribe Therapeutics (NASDAQ: SCTX) is $30.15 last updated September 14, 2026 at 7:56 PM EDT.

Q

Does Scribe Therapeutics (SCTX) pay a dividend?

A

There are no upcoming dividends for Scribe Therapeutics.

Q

When is Scribe Therapeutics (NASDAQ:SCTX) reporting earnings?

A

Scribe Therapeutics does not have any upcoming earnings scheduled.

Q

Is Scribe Therapeutics (SCTX) going to split?

A

There is no upcoming split for Scribe Therapeutics.

Q

What sector and industry does Scribe Therapeutics (SCTX) operate in?

A

Scribe Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved